Exclusively plant, whole-food diet for polypharmacy due to persistent atrial fibrillation, ischaemic cardiomyopathy, hyperlipidaemia and hypertension in an octogenarian

Andrew B Beauchesne, Alan C Goldhamer, Toshia R Myers, Andrew B Beauchesne, Alan C Goldhamer, Toshia R Myers

Abstract

Polypharmacy is common and associated with negative health outcomes in the elderly. We report the case of an 82-year-old man with a history of polypharmacy due to coronary artery disease, myocardial infarction, ischaemic cardiomyopathy, hyperlipidaemia, hypertension and persistent atrial fibrillation who presented with memory loss, cognitive impairment, fatigue and weakness. His treatment plan included an exclusively plant, whole-food diet and moderate physical activity which resulted in a rapid reduction of hyperlipidaemia and high blood pressure and the discontinuation of statin, antihypertensive and beta blocker drug therapy. The patient also reported reversal of impaired cognition and symptoms associated with atrial fibrillation and ischaemic cardiomyopathy, including light-headedness, fatigue and weakness. This case demonstrates that dietary and lifestyle modifications have the potential to improve symptoms of cardiovascular disease and reduce polypharmacy along with associated negative consequences in the elderly.

Keywords: cardiovascular medicine; complementary medicine; diet; geriatric medicine; pharmacology and therapeutics.

Conflict of interest statement

Competing interests: None declared.

© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014;13:57–65. 10.1517/14740338.2013.827660
    1. Dagli RJ, Sharma A. Polypharmacy: a global risk factor for elderly people. J Int Oral Health 2014;6:i–ii.
    1. Machado-Alba JE, Gaviria-Mendoza A, Machado-Duque ME, et al. . Deprescribing: a new goal focused on the patient. Expert Opin Drug Saf 2017;16:111–2. 10.1080/14740338.2017.1273347
    1. Scott IA, Anderson K, Freeman CR, et al. . First do no harm: a real need to deprescribe in older patients. Med J Aust 2014;201:390–2. 10.5694/mja14.00146
    1. Simões PA, Santiago LM, Simões JA. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol. BMJ Open 2018;8:e019542 10.1136/bmjopen-2017-019542
    1. Benjamin EJ, Virani SS, Callaway CW, et al. . Heart disease and stroke statistics-2018 update: a report from the american heart association. Circulation 2018;137:e67–492. 10.1161/CIR.0000000000000558
    1. Eckel RH, Jakicic JM, Ard JD, et al. . 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S76–99. 10.1161/01.cir.0000437740.48606.d1
    1. Stone NJ, Robinson JG, Lichtenstein AH, et al. . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63(25 Pt B):2889–934. 10.1016/j.jacc.2013.11.002
    1. Trewby P, Reddy A, Trewby C, et al. . Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clin Med 2002;2:527–33. 10.7861/clinmedicine.2-6-527
    1. Ho CLB, Breslin M, Doust J, et al. . Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: post hoc analysis of the Australian National Blood Pressure Study. BMJ Open 2018;8:e017723 10.1136/bmjopen-2017-017723
    1. Bays H. Statin safety: an overview and assessment of the data–2005. Am J Cardiol 2006;97(8A):S6–26. 10.1016/j.amjcard.2005.12.006
    1. Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs 2008;8:373–418. 10.2165/0129784-200808060-00004.
    1. Vetter ML, Herring SJ, Sood M, et al. . What do resident physicians know about nutrition? An evaluation of attitudes, self-perceived proficiency and knowledge. J Am Coll Nutr 2008;27:287–98. 10.1080/07315724.2008.10719702
    1. Kolasa KM, Rickett K. Barriers to providing nutrition counseling cited by physicians: a survey of primary care practitioners. Nutr Clin Pract 2010;25:502–9. 10.1177/0884533610380057
    1. Turner-McGrievy G, Mandes T, Crimarco A. A plant-based diet for overweight and obesity prevention and treatment. J Geriatr Cardiol 2017;14:1671–5411. 10.11909/j.issn.1671-5411.2017.05.002
    1. Ferdowsian HR, Barnard ND. Effects of plant-based diets on plasma lipids. Am J Cardiol 2009;104:947–56. 10.1016/j.amjcard.2009.05.032
    1. Wright N, Wilson L, Smith M, et al. . The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes. Nutr Diabetes 2017;7:e256 10.1038/nutd.2017.3
    1. Huang RY, Huang CC, Hu FB, et al. . Vegetarian diets and weight reduction: a meta-analysis of randomized controlled trials. J Gen Intern Med 2016;31:109–16. 10.1007/s11606-015-3390-7
    1. Lindahl O, Lindwall L, Spångberg A, et al. . A vegan regimen with reduced medication in the treatment of hypertension. Br J Nutr 1984;52:11–20. 10.1079/BJN19840066
    1. Chuang SY, Chiu TH, Lee CY, et al. . Vegetarian diet reduces the risk of hypertension independent of abdominal obesity and inflammation: a prospective study. J Hypertens 2016;34:2164–71. 10.1097/HJH.0000000000001068
    1. Yokoyama Y, Nishimura K, Barnard ND, et al. . Vegetarian diets and blood pressure: a meta-analysis. JAMA Intern Med 2014;174:577–87. 10.1001/jamainternmed.2013.14547
    1. Ornish D, Scherwitz LW, Billings JH, et al. . Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998;280:2001–7. 10.1001/jama.280.23.2001
    1. Gómez C, Vega-Quiroga S, Bermejo-Pareja F, et al. . Polypharmacy in the elderly: a marker of increased risk of mortality in a population-based prospective study (NEDICES). Gerontology 2015;61:301–9. 10.1159/000365328

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe